Eva Hellström‐Lindberg

26.2k total citations · 3 hit papers
187 papers, 10.6k citations indexed

About

Eva Hellström‐Lindberg is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Eva Hellström‐Lindberg has authored 187 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Hematology, 90 papers in Genetics and 50 papers in Molecular Biology. Recurrent topics in Eva Hellström‐Lindberg's work include Acute Myeloid Leukemia Research (142 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (41 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Eva Hellström‐Lindberg is often cited by papers focused on Acute Myeloid Leukemia Research (142 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (41 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Eva Hellström‐Lindberg collaborates with scholars based in Sweden, United Kingdom and Germany. Eva Hellström‐Lindberg's co-authors include Anna Porwit, Daniel A. Arber, James W. Vardiman, Clara D. Bloomfield, Ayalew Tefferi, Richard D. Brunning, Michael J. Borowitz, Michelle M. Le Beau, Jüergen Thiele and Nancy L. Harris and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Eva Hellström‐Lindberg

176 papers receiving 10.4k citations

Hit Papers

The 2008 revision of the World Health Organization (WHO) ... 2009 2026 2014 2020 2009 2009 2009 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
    2009 3.0k citations Anna Porwit, Eva Hellström‐Lindberg et al. profile →
  2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    2009 1.8k citations Pierre Fenaux, Ghulam J. Mufti et al. profile →
  3. Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
    2009 698 citations Pierre Fenaux, Ghulam J. Mufti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hellström‐Lindberg Sweden 40 8.2k 4.0k 3.8k 1.4k 1.2k 187 10.6k
Aristoteles Giagounidis Germany 49 8.5k 1.0× 3.4k 0.8× 3.7k 1.0× 1.5k 1.0× 1.2k 1.0× 259 10.3k
Uwe Platzbecker Germany 54 8.8k 1.1× 3.6k 0.9× 4.1k 1.1× 1.6k 1.1× 1.7k 1.5× 543 11.3k
Peter L. Greenberg United States 45 9.1k 1.1× 3.2k 0.8× 3.8k 1.0× 1.4k 1.0× 1.7k 1.5× 203 11.0k
Azra Raza United States 50 8.8k 1.1× 5.5k 1.4× 3.6k 0.9× 1.4k 1.0× 1.6k 1.4× 278 12.3k
Ghulam J. Mufti United Kingdom 55 7.7k 0.9× 4.0k 1.0× 2.9k 0.8× 1.3k 0.9× 1.8k 1.5× 268 11.2k
Steven D. Gore United States 44 6.2k 0.8× 3.6k 0.9× 2.1k 0.5× 1.4k 1.0× 1.2k 1.0× 226 8.1k
Rami S. Komrokji United States 45 5.5k 0.7× 2.6k 0.6× 3.1k 0.8× 788 0.6× 1.2k 1.0× 584 7.5k
Tessa L. Holyoake United Kingdom 59 7.5k 0.9× 3.8k 0.9× 4.7k 1.2× 612 0.4× 2.2k 1.9× 219 11.1k
Hitoshi Kiyoi Japan 46 5.4k 0.7× 4.4k 1.1× 2.0k 0.5× 1.4k 1.0× 2.1k 1.8× 277 9.0k
Courtney D. DiNardo United States 53 10.1k 1.2× 6.6k 1.6× 3.3k 0.9× 2.4k 1.7× 2.6k 2.2× 628 13.5k

Countries citing papers authored by Eva Hellström‐Lindberg

Since Specialization
Citations

This map shows the geographic impact of Eva Hellström‐Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellström‐Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellström‐Lindberg more than expected).

Fields of papers citing papers by Eva Hellström‐Lindberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellström‐Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellström‐Lindberg. The network helps show where Eva Hellström‐Lindberg may publish in the future.

Co-authorship network of co-authors of Eva Hellström‐Lindberg

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hellström‐Lindberg. A scholar is included among the top collaborators of Eva Hellström‐Lindberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hellström‐Lindberg. Eva Hellström‐Lindberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todisco, Gabriele, Teresa Mortera‐Blanco, Ingrid Lilienthal, et al.. (2025). SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms. Leukemia. 39(11). 2801–2811. 1 indexed citations
2.
Campillo‐Marcos, Ignacio, Verónica Dávalos, Gerardo Ferrer, et al.. (2024). Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy. Cancer Research Communications. 4(2). 365–377. 6 indexed citations
3.
Myllymäki, Mikko, Timo Järvinen, Mikko Keränen, et al.. (2024). Somatic mutations associate with clonal expansion of CD8 + T cells. Science Advances. 10(23). eadj0787–eadj0787. 1 indexed citations
4.
Baliakas, Panagiotis, et al.. (2023). The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression. Genes Chromosomes and Cancer. 62(11). 672–677.
5.
6.
Guzzi, Nicola, Sowndarya Muthukumar, Maciej Cieśla, et al.. (2022). Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nature Cell Biology. 24(3). 299–306. 78 indexed citations
7.
Mortera‐Blanco, Teresa, Pedro Luís Moura, Gunilla Walldin, et al.. (2022). The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS. Blood Advances. 6(16). 4705–4709. 2 indexed citations
8.
Kotini, Andriana G., Elsa Bernard, Davide Esposito, et al.. (2022). Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs. Blood Advances. 6(10). 2992–3005. 8 indexed citations
9.
Ohtani, Hitoshi, Andreas Due Ørskov, Linn Gillberg, et al.. (2020). Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine. Cancer Research. 80(12). 2441–2450. 36 indexed citations
10.
Baliakas, Panagiotis, Bianca Tesi, Ulla Wartiovaara‐Kautto, et al.. (2019). Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up. HemaSphere. 3(6). e321–e321. 53 indexed citations
11.
Clements, Mark, et al.. (2019). A longer duration of red blood cell storage is associated with a lower hemoglobin increase after blood transfusion: a cohort study. Transfusion. 59(6). 1945–1952. 14 indexed citations
12.
Liu, Lisa L., Vivien Béziat, Vincent Yi Sheng Oei, et al.. (2017). Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells. Cancer Immunology Research. 5(8). 654–665. 61 indexed citations
13.
Sandmann, Sarah, Aniek O. de Graaf, Mohsen Karimi, et al.. (2017). Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data. Scientific Reports. 7(1). 43169–43169. 121 indexed citations
14.
Johnston, W. Thomas, Alexandra Smith, Louise de Swart, et al.. (2016). Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome. Journal of Internal Medicine. 281(3). 284–299. 22 indexed citations
15.
Ljungström, Viktor, Jakob Werner Hansen, Astrid Olsnes Kittang, et al.. (2016). Molecular Profiling In A Population Based Cohort Of Nordic Myelodysplastic Syndrome Patients. Haematologica. 101. 72–72. 1 indexed citations
16.
17.
Jädersten, Martin, Leonie Saft, Alexander Smith, et al.. (2011). TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression. Journal of Clinical Oncology. 29(15). 1971–1979. 332 indexed citations
18.
Fenaux, Pierre, Ghulam J. Mufti, Eva Hellström‐Lindberg, et al.. (2009). Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia. Journal of Clinical Oncology. 28(4). 562–569. 698 indexed citations breakdown →
19.
Nikpour, Maryam, Andrea Pellagatti, Luca Malcovati, et al.. (2009). NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING. Oxford University Research Archive (ORA) (University of Oxford). 94. 99–99. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aristoteles Giagounidis Breakdown of academic impact, for papers by Uwe Platzbecker Breakdown of academic impact, for papers by Peter L. Greenberg Breakdown of academic impact, for papers by Azra Raza Breakdown of academic impact, for papers by Ghulam J. Mufti Breakdown of academic impact, for papers by Steven D. Gore Breakdown of academic impact, for papers by Rami S. Komrokji Breakdown of academic impact, for papers by Tessa L. Holyoake Breakdown of academic impact, for papers by Hitoshi Kiyoi Breakdown of academic impact, for papers by Courtney D. DiNardo
Rankless by CCL
2026